Literature DB >> 9356637

Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification.

M T Keogan1, V G McDermott, E K Paulson, D H Sheafor, M G Frederick, D M de Long, R C Nelson.   

Abstract

PURPOSE: To determine the relative value of hepatic arterial and portal venous phase helical computed tomographic (CT) scans for tumor detection and vascular opacification in patients with pancreatic malignancy.
MATERIALS AND METHODS: Ninety-five patients who had or were suspected of having pancreatic disease underwent dual-phase helical CT. Arterial phase scans were acquired 20-40 seconds after contrast material administration; venous phase scans, 70-100 seconds after administration. Three readers independently scored images in a blinded fashion for the presence of tumor, for lesion attenuation relative to normal pancreas, and for vascular opacification.
RESULTS: The final diagnosis was pancreatic malignancy (n = 60), acute or chronic pancreatitis (n = 22), and normal pancreas (n = 13). The readers identified possible or definite tumors on arterial phase studies in 47-50 patients and on venous phase studies in 48-53 patients (P > .10). There was no statistically significant difference in tumor attenuation between scans from the two phases (P > .05). Agreement between the readers for tumor detection was not affected by the scanning phase (P > .10). Opacification of arteries and of veins was greater on arterial phase scans and on venous phase scans, respectively (P < .001).
CONCLUSION: The acquisition of arterial phase scans in addition to venous phase scans does not result in improved detection of pancreatic malignancies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356637     DOI: 10.1148/radiology.205.2.9356637

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Utility of fusion CT-PET in the diagnosis of small pancreatic carcinoma.

Authors:  Brian Kim-Poh Goh; Yu-Meng Tan; Yaw-Fui Alexander Chung
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 2.  Imaging of neuroendocrine tumors of the pancreas.

Authors:  J L Fidler; C D Johnson
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 3.  Advances in imaging for pancreatic disease.

Authors:  Chiara Del Frate; Romeo Zanardi; Koenraad Mortele; Pablo R Ros
Journal:  Curr Gastroenterol Rep       Date:  2002-04

4.  Imaging of early pancreatic cancer on multidetector row helical computed tomography.

Authors:  K Takeshita; K Kutomi; T Haruyama; A Watanabe; S Furui; J Fukushima; T Asano
Journal:  Br J Radiol       Date:  2010-05-04       Impact factor: 3.039

Review 5.  Pancreatic adenocarcinoma.

Authors:  Wolfgang Schima; Ahmed Ba-Ssalamah; Claus Kölblinger; Christiane Kulinna-Cosentini; Andreas Puespoek; Peter Götzinger
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 6.  Morphological and functional investigations of neuroendocrine tumors of the pancreas.

Authors:  Philippe L Pereira; Jakub Wiskirchen
Journal:  Eur Radiol       Date:  2003-05-06       Impact factor: 5.315

Review 7.  Intrapancreatic accessory spleen: findings on MR Imaging, CT, US and scintigraphy, and the pathologic analysis.

Authors:  Se Hyung Kim; Jeong Min Lee; Joon Koo Han; Jae Young Lee; Kyoung Won Kim; Kyunghee C Cho; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2008 Mar-Apr       Impact factor: 3.500

8.  The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas.

Authors:  Y Liu; Q Song; H T Jin; X Z Lin; K M Chen
Journal:  Radiol Med       Date:  2009-09-30       Impact factor: 3.469

9.  Isoattenuating insulinomas at biphasic contrast-enhanced CT: frequency, clinicopathologic features and perfusion characteristics.

Authors:  Liang Zhu; Hua-Dan Xue; Hao Sun; Xuan Wang; Yong-Lan He; Zheng-Yu Jin; Yu-Pei Zhao
Journal:  Eur Radiol       Date:  2016-01-26       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.